 | Up a level |
Seipel, Katja; Graber, Carolyn; Flückiger, Laura; Bacher, Vera; Pabst, Thomas (2021). Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia. International journal of molecular sciences, 22(15) MDPI 10.3390/ijms22158092
Kobayashi, Eizaburo; Flückiger, Laura; Kobayashi, Masako; Sawada, Kosaku; Sculean, Anton; Schaller, Benoît; Miron, Richard John (2016). Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clinical oral investigations, 20(9), pp. 2353-2360. Springer 10.1007/s00784-016-1719-1
